Vascular endothelial growth factor enhances macrophage clearance of apoptotic cells.

Efficient clearance of apoptotic cells from the lung by alveolar macrophages is important for the maintenance of tissue structure and function. Lung tissue from humans with emphysema contains increased numbers of apoptotic cells and decreased levels of vascular endothelial growth factor (VEGF). Mice treated with VEGF receptor inhibitors have increased numbers of apoptotic cells and develop emphysema. We hypothesized that VEGF regulates apoptotic cell clearance by alveolar macrophages (AM) via its interaction with VEGF receptor 1 (VEGF R1). Our data show that the uptake of apoptotic cells by murine AMs and human monocyte-derived macrophages is inhibited by depletion of VEGF and that VEGF activates Rac1. Antibody blockade or pharmacological inhibition of VEGF R1 activity also decreased apoptotic cell uptake ex vivo. Conversely, overexpression of VEGF significantly enhanced apoptotic cell uptake by AMs in vivo. These results indicate that VEGF serves a positive regulatory role via its interaction with VEGF R1 to activate Rac1 and enhance AM apoptotic cell clearance.

[1]  M. Elmlinger,et al.  Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD , 2011, Respiratory research.

[2]  K. Ariyoshi,et al.  Monocyte chemoattractant protein-1/CC chemokine ligand 2 enhances apoptotic cell removal by macrophages through Rac1 activation. , 2010, Biochemical and biophysical research communications.

[3]  Russell P Bowler,et al.  Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. , 2009, American journal of respiratory and critical care medicine.

[4]  W. Janssen,et al.  Lung environment determines unique phenotype of alveolar macrophages. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[5]  D. Meyerholz,et al.  Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response. , 2009, Developmental and comparative immunology.

[6]  S. Hodge,et al.  Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[7]  W. Janssen,et al.  Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. , 2008, American journal of respiratory and critical care medicine.

[8]  Michiyuki Matsuda,et al.  Spatiotemporal activation of Rac1 for engulfment of apoptotic cells , 2008, Proceedings of the National Academy of Sciences.

[9]  A. Fitzpatrick,et al.  Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. , 2008, The Journal of allergy and clinical immunology.

[10]  J. V. van Buul,et al.  VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2. , 2007, Experimental cell research.

[11]  Chung-Ming Chen,et al.  High-dose vascular endothelial growth factor increases surfactant protein gene expressions in preterm rat lung. , 2007, Early human development.

[12]  S. Hodge,et al.  Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. , 2007, American journal of respiratory cell and molecular biology.

[13]  D. A. Hanson,et al.  Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors , 2006, Oncogene.

[14]  A. Ridley,et al.  Differential regulation of phagosome maturation in macrophages and dendritic cells mediated by Rho GTPases and ezrin–radixin–moesin (ERM) proteins , 2006, Proceedings of the National Academy of Sciences.

[15]  B. Ma,et al.  Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Bowler,et al.  Lovastatin Enhances Clearance of Apoptotic Cells (Efferocytosis) with Implications for Chronic Obstructive Pulmonary Disease1 , 2006, The Journal of Immunology.

[17]  T. Flotte,et al.  A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema. , 2006, American journal of respiratory and critical care medicine.

[18]  I. Douglas,et al.  Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. , 2006, Chest.

[19]  S. Wenzel,et al.  Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. , 2005, American journal of respiratory and critical care medicine.

[20]  Michael O. Hengartner,et al.  Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C. elegans , 2005, Nature.

[21]  R. Homer,et al.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.

[22]  S. Hodge,et al.  Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells , 2003, Immunology and cell biology.

[23]  N. Voelkel,et al.  Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. , 2003, American journal of respiratory cell and molecular biology.

[24]  M. Walport,et al.  Role of Surfactant Proteins A, D, and C1q in the Clearance of Apoptotic Cells In Vivo and In Vitro: Calreticulin and CD91 as a Common Collectin Receptor Complex1 , 2002, The Journal of Immunology.

[25]  L. Benjamin,et al.  Placental growth factor is a survival factor for tumor endothelial cells and macrophages. , 2002, Cancer research.

[26]  E. Puré,et al.  Resolution of Lung Inflammation by CD44 , 2002, Science.

[27]  A. Ridley,et al.  Phosphatidylserine (PS) induces PS receptor–mediated macropinocytosis and promotes clearance of apoptotic cells , 2001, The Journal of cell biology.

[28]  K. Goss,et al.  VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[29]  R. Crystal,et al.  Compartmentalization of Vascular Endothelial Growth Factor to the Epithelial Surface of the Human Lung , 2001, Molecular medicine.

[30]  D A Lynch,et al.  Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. , 2001, American journal of respiratory and critical care medicine.

[31]  K. Shitara,et al.  and surface marker for the lineage of monocyte-macrophages in humans Flt-1 , vascular endothelial growth factor receptor 1 , is a novel cell , 2001 .

[32]  曽我 倫久人.  Rac Regulates Vascular Endothelial Growth Factor Stimulated Motility , 2001 .

[33]  M. Persico.  Placenta Growth Factor , 2001 .

[34]  P. Hirth,et al.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.

[35]  H. Katus,et al.  Decreased apoptosis and increased activation of alveolar neutrophils in bacterial pneumonia. , 2000, Chest.

[36]  T. Noda,et al.  Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. Chi,et al.  Neutrophil apoptosis in the acute respiratory distress syndrome. , 1997, American journal of respiratory and critical care medicine.

[38]  G. Breier,et al.  The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.

[39]  J. Winer,et al.  Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. , 1994, The Journal of biological chemistry.

[40]  H. Dvorak,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[41]  M. Walport,et al.  Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. , 1989, The Journal of clinical investigation.